ArticleiScience2024

RHOF activation of AKT/β-catenin signaling pathway drives acute myeloid leukemia progression and chemotherapy resistance.

Xin Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.